Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Jaeb Center for Health Research
Study ID
NCT06837181
Status
Recruiting
Apply to this trial

Conditions

  • Blood Pressure
  • Cardiovascular Risk
  • Cystic Fibrosis (CF)
  • Cystic Fibrosis-related Diabetes
  • Diabetes
  • Microvascular
  • Nephropathy
  • Neuropathy
  • Retinopathy

Eligibility Criteria

Sex
ALL
Age
12 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • observational study — OTHER
    This is an observational study.

Study Details

This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.

Key Dates

Start date
Sep 18, 2025
Status verified
Feb 2026
Primary completion
Nov 30, 2028
Completion
Nov 30, 2028

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Individuals with Cystic Fibrosis-Related Diabetes
    Individuals diagnosed with Cystic Fibrosis-Related Diabetes for more than 5 years before enrollment

Primary Outcome Measure

Microvascular Complications [ Time Frame: From enrollment to the end of the participant's participation or 4 weeks ]

Central Contacts

Locations (18)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35233
George Solomon
[email protected]
205-638-5599
Keck Medical Center of USCLos AngelesCalifornia90033
Adupa Rao
[email protected]
323-442-8522
Stanford UniversityPalo AltoCalifornia94304
Carlos Milla
[email protected]
650-721-1132
University of California San DiegoSan DiegoCalifornia92103
Jacob Bailey
[email protected]
858-246-0371
University of Colorado DenverAuroraColorado80045
Christine Chan, MD
[email protected]
720-777-6128
University of MiamiMiamiFlorida33136
Maria Tupayachi Ortiz
[email protected]
305-799-9209
Emory University School of MedicineAtlantaGeorgia30322
Tanicia Daley, MD MPH
[email protected]
404-727-2503
University of IowaIowa CityIowa52242
Katie Larson Ode, MD
[email protected]
319-356-4443
Tulane UniversityNew OrleansLouisiana70112
Ross Klingsberg
[email protected]
504-400-4316
MassachusettsBostonMassachusetts02114
Melissa Putman
[email protected]
University of MinnesotaMinneapolisMinnesota55455
Amir Moheet, MD
[email protected]
617-624-3209
University of New MexicoAlbuquerqueNew Mexico87106
Kamyron Jordan
[email protected]
505-272-9889
Columbia University Cystic Fibrosis ProgramNew YorkNew York10032
Hossein Sadeghi
[email protected]
212-305-5122
Atrium Health Wake Forest Baptist (Wake Forest Baptist)Winston-SalemNorth Carolina27104
Chad Marion
[email protected]
336-713-8550
The Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19146
Andrea Kelly, MD
[email protected]
215-590-3174
Medical University of South CarolinaCharlestoneSouth Carolina29425
Christina Mingora
[email protected]
843-792-3163
Baylor College of MedicineHoustonTexas77030
Michelle Mann
[email protected]
8328224772
The University of Texas Health Science Center at San AntonioSan AntonioTexas78229
Maria Rayas, MD
[email protected]
210-567-5283

Find similar trials in Birmingham, AL

By research site
University of Alabama at Birmingham· Birmingham, ALKeck Medical Center of USC· Los Angeles, CAStanford University· Palo Alto, CAUniversity of California San Diego· San Diego, CAUniversity of Colorado Denver· Aurora, COUniversity of Miami· Miami, FL

Related Studies